ETHZilla Corporation (ETHZ)

Q: Does ETHZ pay dividends?

ETHZilla Corporation (ETHZ) does not currently pay a regular dividend.

Official site

BIOTECHNOLOGY

$3.04

-0.48 (-13.64%)

Last updated: Nov 05, 2026 at 4:00 PM ET

Earnings

Performance (10Y)

Beat Rate

67%(4/6)

Avg Surprise

-1575.23%

Last 12 of 23 reported quarters

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Sep 30, 2025Sep 25 Reported Nov 14, 2025Reported Nov 14	$-16.80	N/A	-	N/A	Beat	-	-	-96.9%
Jun 30, 2025Jun 25 Reported Jul 23, 2025Reported Jul 23	$-3.02	N/A	-	N/A	Beat	-	-	-2455.7%
Mar 31, 2025Mar 25 Reported May 15, 2025Reported May 15	$-0.67	N/A	-	N/A	Beat	-	-	+96.0%
Dec 31, 2024Dec 24 Reported Mar 31, 2025Reported Mar 31	$-10.95	N/A	-	N/A	Beat	-	-	+52.3%
Sep 30, 2024Sep 24 Reported Nov 27, 2024Reported Nov 27	$-8.53	N/A	-	N/A	Beat	-	-	+96.5%
Jun 30, 2024Jun 24 Reported Aug 6, 2024Reported Aug 6	$0.13	N/A	-	N/A	Beat	-	-	+100.1%
Mar 31, 2024Mar 24 Reported May 29, 2024Reported May 29	$-16.76	N/A	-	N/A	Beat	-	-	+93.1%
Dec 31, 2023Dec 23 Reported Feb 28, 2024Reported Feb 28	$-22.95	N/A	-	N/A	Beat	-	-	-135.4%
Sep 30, 2023Sep 23 Reported Nov 29, 2023Reported Nov 29	$-245.28	N/A	-	N/A	Beat	-	-	-44497.3%
Jun 30, 2023Jun 23 Reported Aug 8, 2023Reported Aug 8	$-133.66	N/A	-	N/A	Beat	-	-	-148614.8%
Mar 31, 2023Mar 23 Reported May 31, 2023Reported May 31	$-241.46	N/A	-	N/A	Beat	-	-	-483025.0%
Dec 31, 2022Dec 22 Reported Mar 1, 2023Reported Mar 1	$-9.75	$-0.11	-	-8763.64%	Miss	-	-	-32600.0%

Key Metrics

Valuation
P/E Ratio	N/A	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	N/A	Operating Margin	N/A
ROE	N/A	ROIC	N/A
Financial Health
Debt/Equity	1.23x	Interest Coverage	N/A
Current Ratio	10.07x	Quick Ratio	10.07x
Trading Statistics
Beta	N/A	Avg Volume	141.23K
52-Week High	N/A	52-Week Low	N/A

Technical Indicators Dashboard

Moving Averages

SMA 10$3.45

SMA 20$3.61

SMA 50$4.41

SMA 200$4.47

EMA 10$3.44

EMA 20$3.67

EMA 50$4.25

EMA 200$6.10

MACD

Line: -0.33Signal: -0.35Hist: 0.02

ADX

ADX: 28.8+DI: 19.4-DI: 30.3

Aroon & PSAR

Aroon Up20.0

Aroon Down100.0

PSAR$3.99

Bollinger Bands

Upper Band$4.37

Lower Band$2.85

%B Position4204%(Upper)

Band Width0.12

RSI (14-Day)

Neutral

32.8

Momentum Oscillators

Stoch %K30.7

Stoch %D32.4

Williams %R-97.9

ROC (10d)-8.7%

Momentum-0.29

CCI (20d)-106.6

MFI (14d)44.6

Volatility Measures

ATR (14d)$0.34(11.0%)

StdDev (20d)0.38

Hist Vol90.1%(High)

Volume Flow

VWAP$3.16

OBV123.1M

AD Line119.8B

CMF (20d)-0.237

Volume Metrics

Avg Vol (20d)144.9K

Vol Ratio0.9x

VWMA (20d)$3.54

Pivot Points

R3$3.93

R2$3.76

R1$3.64

Pivot Point$3.48

S1$3.36

S2$3.19

S3$3.07

Advanced Oscillators

TSI-30.32

Ultimate Osc38.3

KST-250.10

Financial Data

Quarter	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022
Total Revenue	$4.11M	$0	$0	$95,114	$0	$0	N/A	$166,030	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	$47,557	$13,851	$23,981	$23,576	$83,015	$32,693	$28,550	$21,772	$37,608
Gross Profit	$4.11M	N/A	N/A	$47,557	$-13,851	$-23,981	$-23,576	$83,015	$-32,693	$-28,550	$-21,772	$-37,608

Operating Expenses	$224.60M	$1.73M	$2.37M	$1.41M	$979,093	$1.85M	$2.07M	$1.45M	$3.54M	$3.68M	$4.80M	$5.64M
R&D	$0	$182,386	$240,905	$408,836	$402,715	$252,526	$535,728	$36,362	$1.10M	$920,904	$794,993	$585,690
SG&A	$224.60M	$1.41M	$2.00M	$997,594	$576,378	$1.59M	$1.56M	$1.49M	$2.43M	$2.76M	$4.01M	$5.05M
Operating Income	$-220,494,363	$-1,730,415	$-2,372,968	$-1,406,430	$-979,093	$-1,846,738	$-2,092,470	$-1,452,488	$-3,538,187	$-3,682,980	$-4,803,845	$-5,639,896

Interest Income	$327,211	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Interest Expense	$319,909	$2,672	$2,655	$9,198	$13,633	$11,360	$16,449	$10,032	$11,634	$11,606	$11,556	$4,550
Income Before Tax	$-208,670,965	$-1,726,604	$-2,369,232	$-4,569,518	$-836,720	$11,781	$-1,069,744	$-1,231,494	$-12,610,785	$-3,680,169	$-4,762,078	$-22,685,027
Income Tax Expense	$8.07M	$0	$0	$-296,024	$0	$0	$0	$-4,389	$-2,345,025	$0	$0	$-942,749

Net Income	$-216,742,056	$-1,726,604	$-2,369,232	$-4,273,494	$-836,720	$11,781	$-1,069,744	$-1,227,105	$-10,265,760	$-3,680,169	$-4,762,078	$-21,742,278

EBITDA	$-220,494,363	$-1,730,415	$-2,372,968	$-4,560,320	$-809,236	$47,122	$-1,029,719	$-1,198,802	$-12,566,458	$-3,640,013	$-4,728,750	$-22,642,869
EBIT	N/A	$-1,744,984	$-2,387,537	$-4,557,189	$-823,087	$23,141	$-1,053,295	$-1,221,462	$-12,599,151	$-3,668,563	$-4,750,522	$-22,680,477

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about ETHZ

News

No news available

Company news will appear here when available

ETHZ Valuation and Fair Value

P/B: 0.1x

See GNG's fair value

ETHZ Competitors

Company	Ticker
Elicio Therapeutics Inc.	ELTX
Veru Inc	VERU
Scynexis Inc	SCYX
Grace Therapeutics, Inc.	GRCE
eXoZymes, Inc.	EXOZ
Pelthos Therapeutics Inc.	PTHS
Harvard Bioscience Inc	HBIO
INmune Bio Inc	INMB

Sector: Healthcare

ETHZ Earnings: Beat Rate and Next Report

Beat rate: 4 of 8 quarters (50.0%)
Average surprise: -1575.2%

ETHZ ETF Holders

GNG tracks 1 ETF that holds ETHZ.

Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund

Open the ETF Stock Exposure tool for ETHZ

Frequently Asked Questions About ETHZ

Does ETHZ pay dividends?